Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Chang and Son Enterprises, Inc.
WARNING LETTER
•Chang and Son Enterprises, Inc.•February 8, 2024

FDA WARNING_LETTER - Chang and Son Enterprises, Inc. - February 08, 2024

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On May 31, 2024, the FDA issued a Warning Letter to Mr. Chang, following an analysis of environmental samples collected on December 20, 2023, by the Commonwealth of Massachusetts Department of Agricultural Resources (MDAR) from a sprouting operation at 301 River Road, Whately, MA. Two of fifteen environmental swabs tested positive for *Listeria monocytogenes* (*L. monocytogenes*).

The FDA determined that the mung bean and soybean sprouts were adulterated under section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act), 21 U.S.C. § 342(a)(4), due to insanitary conditions. Whole Genome Sequence (WGS) analysis revealed that isolates from the December 20, 2023, environmental sample matched ten other *L. monocytogenes* isolates from product samples collected between April 23, 2023, and December 4, 2023. This led to a determination that mung bean sprouts were contaminated under section 402(a)(1) of the Act, 21 U.S.C. § 342(a)(1), containing a poisonous or deleterious substance.

Previous positive findings of *L. monocytogenes* in mung bean sprouts were identified on April 24,

Company
Chang and Son Enterprises, Inc.
Inspection Date
February 8, 2024
Product Type
Food
Office
Division of Human and Animal Food Operations - East I
Person
  • Ronald M. Pace (Program Director)
Open in Dashboard

ID · 5b6579d6-7e8e-4b52-a4d0-ffa53541bd2a

Violation Codes3
21 U.S.C. 342(a)(4)21 U.S.C. 342(a)(1)21 CFR 112

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.